Stay updated with breaking news from Diagnostics Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
![F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Corporate Executive Committee in January 2023 - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
Basel, 3 October 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Matt Sause (45), currently Head of Roche Diagnostics' North America Region, will become CEO Roche Diagnostics and a member
The FINANCIAL -- Commenting on the Group’s first nine months, Roche CEO Severin Schwan said: “We had continued good sales growth in both Pharmaceuticals and Diagnostics driven by our newly launched products, and our product pipeline is developing very well. Our cancer immunotherapy medicine Tecentriq has been performing strongly since May, when it was first approved in the US for people with advanced bladder cancer, and it has just received US FDA approval for previously treated metastatic non-small cell lung cancer. Based on our performance so far, I am confident that we will meet our ful...
Christoph Franz has decided not to seek re-election to the Board of Directors at the Annual General Meeting (AGM) in March 2023 The Board of Directors intends to propose Severin Schwan as new Chairman
Basel, 21 July 2022 Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Division sales increase 3%; continued strong demand for new medicines to treat severe
Roche's (RHHBY) (RHHBF) Diagnostics division head will take over as Group CEO, replacing incumbent Severin Schwan, effective March 15, 2023.The Swiss company's board intends to...